Skip to main content

In Memoriam: David J. Galas, Ph.D. (1944-2023) >>

About Us
Grants
Startup Investments
- Investing in Washington
- Active Portfolio & Exits
Stories
News
- Articles
- Videos
- Reports
Contact

Keywords:

How RNA-altering drugs might improve anticancer immunotherapies

Post navigation

← Computers Design Precise Genetic Programs Vancouver, Wash. biotech company Absci files to go public →

Comments are closed.

Home
Contact

About Us

Grants

Startup Investments
- Investing in Washington
- Active Portfolio & Exits
In Memoriam: David Galas, Ph.D. (1944-2023)

News
- Articles
- Videos
- Stories

LinkedIn
Twitter

Washington Research Foundation values diversity. We’re committed to diversity, equity and inclusion in our staff, our board of directors, and the researchers, entrepreneurs and organizations we fund. We encourage people of color, women and other underserved communities to apply for our employment, grant-making and investment opportunities.

© 2023 Washington Research Foundation, Seattle WA

Terms of Use
Privacy Policy
(206) 336-5600
Site by The Medium

About Us
Grants
Startup Investments
- Investing in Washington
- Active Portfolio & Exits
Stories
News
- Articles
- Videos
- Reports
Contact